NEW YORK STOCK EXCHANGE, INC. · BHVN
+12.31% · +$1.67 · Vol 2.0M
Biohaven Ltd

Biohaven Ltd

Biotechnology
$15.24
+ Add to watchlist
Card

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is BHVN moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Biohaven Ltd
PHARMACEUTICAL PREPARATIONS
Listed since
2022
Employees
274
Country
US

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$14.07
Day high
$15.64
Day low
$14.07
Previous close
$13.57
52W high
$15.64
-2.59% from high
52W low
$11.07
91% of range
Market cap
$2B
EPS
$-6.6300
Shares out
150.6M
Volume
2M
VWAP
$15.10
Price history computed in-house
1W
+26.06%
SMA 50 $12.49 · above
SMA 200 $12.49 · above
52W position 91%
Veridion warehouse edge

Warehouse intelligence for BHVN.

Veridion Score
67
0: 311: 572: 783: 504: 765: Not reported
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
None on file
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

BHVN insider activity

Biohaven Ltd

Score
Coverage building
Pressure
Net buying
Filings
10
Buys / sells
5 / 5
Net value
$33.0M
Insiders
7
Named filers
BM
Buten Matthew
Insider
Leadership
CC
Clark George C.
Insider
Leadership
CB
Car Bruce
Insider
Leadership
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Net buying: $33.0M across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing dateTrade dateInsiderTitleTypePriceQtyOwnedValueReceipt
2026-01-072026-01-05Buten MatthewInsidersell$9.932,594195,652$26KSEC Form 4
2026-01-072026-01-05Clark George C.Insidersell$9.931,11766,978$11KSEC Form 4
2026-01-072026-01-05Car BruceInsidersell$9.932,3817,715$24KSEC Form 4
2026-01-072026-01-05Coric VladInsidersell$9.937,4301,803,968$74KSEC Form 4
2026-01-072026-01-05Gentile KimberlyInsidersell$9.931,95699,557$19KSEC Form 4
Full Form 4 history requires Sovereign

Showing 5 recent rows. Sovereign unlocks 5 additional rows, full sorting, and the named-filer history.

Upgrade to Sovereign · $25/mo
Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

BHVN contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for BHVN in this window.
Lobbying spend

BHVN lobbying filings, year to date.

Registered lobbying filings matched to Biohaven Ltd.

$200.0K
Refresh interval: 12hSource: LDA disclosure filings
Health IssuesMedical/Disease Research/Clinical Labs Pharmacy Health Issues
Filing
$80.0K
BIOHAVEN LTD.

CHECKMATE GOVERNMENT RELATIONS

Apr 19, 2026
Filing
$60.0K
BIOHAVEN PHARMACEUTICALS INC.

DLA PIPER LLP (US)

Apr 20, 2026
Filing
$60.0K
BIOHAVEN PHARMACEUTICALS INC.

DLA PIPER LLP (US)

Jan 16, 2026
Latest news · BHVN
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for BHVN.
Options
Sovereign unlock shows live options positioning for BHVN.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.